245 related articles for article (PubMed ID: 32350187)
1. Optimal Treatment for Tenosynovial Giant Cell Tumor of the Hand.
Kitagawa Y; Takai S
J Nippon Med Sch; 2020 Sep; 87(4):184-190. PubMed ID: 32350187
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of CSF1 immunohistochemistry in tenosynovial giant cell tumor for differentiating from giant cell-rich tumors and tumor-like lesions of bone and soft tissue.
Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Shimizu J; Murahashi Y; Emori M; Hasegawa T
Diagn Pathol; 2022 Nov; 17(1):88. PubMed ID: 36320082
[TBL] [Abstract][Full Text] [Related]
3. Massively parallel sequencing of tenosynovial giant cell tumors reveals novel CSF1 fusion transcripts and novel somatic CBL mutations.
Tsuda Y; Hirata M; Katayama K; Motoi T; Matsubara D; Oda Y; Fujita M; Kobayashi H; Kawano H; Nishida Y; Sakai T; Okuma T; Goto T; Ogura K; Kawai A; Ae K; Anazawa U; Suehara Y; Iwata S; Miyano S; Imoto S; Shibata T; Nakagawa H; Yamaguchi R; Tanaka S; Matsuda K
Int J Cancer; 2019 Dec; 145(12):3276-3284. PubMed ID: 31107544
[TBL] [Abstract][Full Text] [Related]
4. Medium-term Outcomes of Excision Using Surgical Microscope of Tenosynovial Giant Cell Tumors of the Hand.
Nakamura Y; Tada K; Akahane M; Honda S; Horie S; Ikeda K; Tsuchiya H
Anticancer Res; 2024 Jan; 44(1):375-378. PubMed ID: 38159975
[TBL] [Abstract][Full Text] [Related]
5. Tenosynovial giant cell tumor in the foot and ankle.
Çevik HB; Kayahan S; Eceviz E; Gümüştaş SA
Foot Ankle Surg; 2020 Aug; 26(6):712-716. PubMed ID: 31526689
[TBL] [Abstract][Full Text] [Related]
6. The surgical outcome and recurrence rate of tenosynovial giant cell tumor in the elbow: a literature review.
Al Farii H; Zhou S; Turcotte R
J Shoulder Elbow Surg; 2019 Sep; 28(9):1835-1840. PubMed ID: 31447124
[TBL] [Abstract][Full Text] [Related]
7. Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis).
Gouin F; Noailles T
Orthop Traumatol Surg Res; 2017 Feb; 103(1S):S91-S97. PubMed ID: 28057477
[TBL] [Abstract][Full Text] [Related]
8. Tenosynovial Giant Cell Tumor in the Hand: Experience with 173 Cases.
Çevik HB; Kayahan S; Eceviz E; Gümüştaş SA
J Hand Surg Asian Pac Vol; 2020 Jun; 25(2):158-163. PubMed ID: 32312203
[No Abstract] [Full Text] [Related]
9. A novel colony-stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor.
Lipplaa A; Meijer D; van de Sande MAJ; Gelderblom H; Bovée JVMG; Mei H; Szuhai K
Genes Chromosomes Cancer; 2023 Apr; 62(4):223-230. PubMed ID: 36504457
[TBL] [Abstract][Full Text] [Related]
10. Tenosynovial Giant Cell Tumor, Localized Type With Extensive Chondroid Metaplasia: A Case Report With Immunohistochemical and Molecular Genetic Analysis.
Nagase M; Araki A; Ishikawa N; Nagano N; Fujimoto M; Biyajima K; Yamagami N; Yamamoto S; Maruyama R
Int J Surg Pathol; 2020 Jun; 28(4):447-453. PubMed ID: 31771368
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of diffuse tenosynovial giant cell tumor arising from temporomandibular joints].
Meng JH; Guo YX; Luo HY; Guo CB; Ma XC
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1049-1054. PubMed ID: 27987512
[TBL] [Abstract][Full Text] [Related]
12. Prediction of local recurrence in tenosynovial giant cell tumor of the knee: Based on preoperative MRI evaluation into disease subtypes and severity.
Kim JH; Lee SK; Kim JY
PLoS One; 2023; 18(6):e0287028. PubMed ID: 37315053
[TBL] [Abstract][Full Text] [Related]
13. Clinical and morphological correlations and histopathology of joint damage in patients with diffuse-type tenosynovial giant cell tumor.
Dyadyk OO; Hryhorovska AV
Wiad Lek; 2019; 72(12 cz 1):2269-2276. PubMed ID: 32124739
[TBL] [Abstract][Full Text] [Related]
14. Diffuse-Type Tenosynovial Giant Cell Tumor: What Are the Important Findings on the Initial and Follow-Up MRI?
Choi WS; Lee SK; Kim JY; Kim Y
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254890
[TBL] [Abstract][Full Text] [Related]
15. Tenosynovial Giant Cell Tumor (TSGCT) of the hip: MRI accuracy and results of surgical treatment.
Schenk P; Schöni M; Urbanschitz L; Filli L; Rahm S; Zing P
Acta Orthop Belg; 2023 Mar; 89(1):65-69. PubMed ID: 37294987
[TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study.
Mastboom MJL; Palmerini E; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Staals EL; Schaap GR; Jutte PC; Aston W; Gelderblom H; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; ; van de Sande MAJ
Lancet Oncol; 2019 Jun; 20(6):877-886. PubMed ID: 31029509
[TBL] [Abstract][Full Text] [Related]
17. Imaging characteristics of tenosynovial giant cell tumors on
Mizuta K; Oshiro H; Tsuha Y; Tome Y; Nishida K
BMC Musculoskelet Disord; 2023 Jul; 24(1):593. PubMed ID: 37468883
[TBL] [Abstract][Full Text] [Related]
18. Tenosynovial giant cell tumor-diffuse type, treated with a novel colony-stimulating factor inhibitor, pexidartinib: initial experience with MRI findings in three patients.
Helming A; Hansford B; Beckett B
Skeletal Radiol; 2022 May; 51(5):1085-1091. PubMed ID: 34586485
[TBL] [Abstract][Full Text] [Related]
19. Tenosynovial giant cell tumor of the cervical spine: a case report.
Furuhata R; Iwanami A; Tsuji O; Nagoshi N; Suzuki S; Okada E; Fujita N; Yagi M; Matsumoto M; Nakamura M; Watanabe K
Spinal Cord Ser Cases; 2019; 5():23. PubMed ID: 31240119
[TBL] [Abstract][Full Text] [Related]
20. Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?
Mastboom MJL; Hoek DM; Bovée JVMG; van de Sande MAJ; Szuhai K
Histopathology; 2019 Jan; 74(2):332-340. PubMed ID: 30152874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
